Skip to content

Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy

Image: Domizia Salusest | www.domiziasalusest.com

Protease inhibitor drug suppresses HIV in semen more slowly than drugs from other classes

MDR-TB numbers could keep growing despite improved treatment

Switching from efavirenz to lopinavir/ritonavir has no meaningful impact on neurological function, says UK study

Undocumented migrants more likely to be lost to follow-up and have poor virological outcomes after starting ART, Milan study confirms

Besifovir and tenofovir exalidex look promising as new hepatitis B drugs

Tawesak Tanwandee at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com

Naloxone is a heath intervention that can’t be effectively provided without the knowledge and social connections of people who inject drugs

Fear of stigma is prompting young South Africans to seek early HIV treatment

Increased screening for syphilis boosts detection of early latent infections among Australian gay men